Location: New York, NY
CIK: 0001534261 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $1.61B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WGS | GENEDX HOLDINGS CORP | 3,007,164 | $391M | 24.3% | $9.11 | +1406.1% | COM CL A | 81663L200 |
| RVMD | REVOLUTION MEDICINES INC | 2,577,333 | $205M | 12.8% | $25.89 | +153.2% | COM | 76155X100 |
| BLFS | BIOLIFE SOLUTIONS INC | 5,957,165 | $144M | 8.9% | $19.43 | +34.7% | COM NEW | 09062W204 |
| LAB | STANDARD BIOTOOLS INC | 88,783,856 | $114M | 7.1% | $2.16 | -37.9% | COM | 34385P108 |
| RLAY | RELAY THERAPEUTICS INC | 13,003,574 | $110M | 6.8% | $15.13 | -52.8% | COM | 75943R102 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,175,000 | $81.72M | 5.1% | $28.16 | — | SPONSORED ADS | 86366E106 |
| ILMN | ILLUMINA INC | 600,000 | $78.7M | 4.9% | $116.59 | +0.7% | COM | 452327109 |
| RNAM | AVIDITY BIOSCIENCES INC | 1,000,000 | $72.13M | 4.5% | $14.11 | +357.9% | COM | 05370A108 |
| BEAM | BEAM THERAPEUTICS INC | 1,600,000 | $44.35M | 2.8% | $36.48 | -30.1% | COM | 07373V105 |
| GH | GUARDANT HEALTH INC | 380,000 | $38.81M | 2.4% | $72.99 | +22.6% | COM | 40131M109 |
| MAZE | MAZE THERAPEUTICS INC | 758,857 | $31.44M | 2.0% | $12.04 | +185.5% | COM | 578784100 |
| DNLI | DENALI THERAPEUTICS INC | 1,840,000 | $30.38M | 1.9% | $22.98 | -26.5% | COM | 24823R105 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 75,000 | $29.82M | 1.9% | $219.27 | +101.8% | COM | 02043Q107 |
| NGNE | NEUROGENE INC | 1,295,361 | $26.68M | 1.7% | $27.94 | -10.9% | COM | 64135M105 |
| TXG | 10X GENOMICS INC | 1,400,000 | $22.83M | 1.4% | $15.11 | 0.0% | CL A COM | 88025U109 |
| SPRY | ARS PHARMACEUTICALS INC | 1,600,000 | $18.64M | 1.2% | $14.35 | -32.2% | COM | 82835W108 |
| TEM | TEMPUS AI INC | 294,127 | $17.37M | 1.1% | $70.04 | +11.7% | CL A | 88023B103 |
| UNH | UNITEDHEALTH GROUP INC | 50,000 | $16.51M | 1.0% | $318.07 | +6.0% | COM | 91324P102 |
| SEPN | SEPTERNA INC | 553,268 | $15.43M | 1.0% | $23.65 | +1.0% | COM | 81734D104 |
| HIMS | HIMS & HERS HEALTH INC | 385,000 | $12.5M | 0.8% | $40.06 | +6.9% | COM CL A | 433000106 |
| VCYT | VERACYTE INC | 276,308 | $11.63M | 0.7% | $24.40 | +65.2% | COM | 92337F107 |
| DXCM | DEXCOM INC | 175,000 | $11.61M | 0.7% | $64.65 | 0.0% | COM | 252131107 |
| SRRK | SCHOLAR ROCK HLDG CORP | 260,000 | $11.45M | 0.7% | $37.51 | 0.0% | COM | 80706P103 |
| CI | THE CIGNA GROUP | 40,000 | $11.01M | 0.7% | $279.23 | 0.0% | COM | 125523100 |
| PRME | PRIME MEDICINE INC | 3,167,175 | $10.99M | 0.7% | $4.73 | -6.0% | COM | 74168J101 |
| INCY | INCYTE CORP | 100,000 | $9.877M | 0.6% | $79.04 | +22.4% | COM | 45337C102 |
| DGX | QUEST DIAGNOSTICS INC | 50,000 | $8.677M | 0.5% | $182.07 | 0.0% | COM | 74834L100 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,500,000 | $8.25M | 0.5% | $4.86 | 0.0% | COM SHS | 877619106 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 4,223,767 | $7.898M | 0.5% | $3.55 | -45.9% | COM | 69404D108 |
| LEGN | LEGEND BIOTECH CORP | 215,000 | $4.674M | 0.3% | $21.74 | — | SPONSORED ADS | 52490G102 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 282,312 | $3.535M | 0.2% | $11.58 | — | COM NEW | 107924102 |
| ABSI | ABSCI CORPORATION | 973,260 | $3.397M | 0.2% | $19.41 | -81.2% | COM | 00091E109 |
| CTNM | CONTINEUM THERAPEUTICS INC | 148,333 | $1.695M | 0.1% | $16.10 | -29.2% | CL A | 21217B100 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 86,014 | $1.349M | 0.1% | $20.37 | -33.8% | COM | 61225M102 |
| IPSC | CENTURY THERAPEUTICS INC | 1,228,190 | $1.222M | 0.1% | $10.97 | -94.4% | COM | 15673T100 |
| RXRX | RECURSION PHARMACEUTICALS IN | 165,323 | $676K | 0.0% | $6.72 | -26.3% | CL A | 75629V104 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 36,493 | $303K | 0.0% | $10.02 | +7.4% | CL A NEW | 37611X209 |
| TNYA | TENAYA THERAPEUTICS INC | 361,969 | $258K | 0.0% | $12.86 | -89.4% | COM | 87990A106 |